Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Knapp

Showing results (1-10 of 539) with videos related to

Pageof 54
Sort By:
Handbook of Experimental Pharmacology|November 11, 2015
Emerging Target Families: Intractable TargetsStefan Knapp
British Journal of Cancer|March 17, 2018
New opportunities for kinase drug repurposing and target discoveryStefan Knapp
EMBO Molecular Medicine|August 7, 2013
Testis specific gene expression drives disease progression and Rituximab resistance in lymphomaStefan Knapp
Structure (London, England : 1993)|August 15, 2009
Out of the box binding determines specificity of SH2 domain interactionSusanne Müller, Stefan Knapp
Biochimica Et Biophysica Acta|October 27, 2009
Insights into protein kinase regulation and inhibition by large scale structural comparisonJeyanthy Eswaran, Stefan Knapp
Nature Chemical Biology|October 16, 2023
Improving data quality in chemical biologyStefan Knapp, Susanne Müller
Current Opinion in Pharmacology|August 13, 2014
Recently targeted kinases and their inhibitors-the path to clinical trialsStefan Knapp, Michael Sundström
Expert Opinion on Drug Discovery|July 25, 2012
Targeting kinases for the treatment of inflammatory diseasesSusanne Müller, Stefan Knapp
Trends in Biotechnology|July 19, 2018
Chemoproteomics and Chemical Probes for Target DiscoveryGerard Drewes, Stefan Knapp
Nature Reviews. Drug Discovery|April 23, 2014
Targeting bromodomains: epigenetic readers of lysine acetylationPanagis Filippakopoulos, Stefan Knapp
Pageof 54

Showing results (1-10 of 539) with videos related to

Sort By:
Pageof 54
Handbook of Experimental Pharmacology|November 11, 2015
Emerging Target Families: Intractable TargetsStefan Knapp
British Journal of Cancer|March 17, 2018
New opportunities for kinase drug repurposing and target discoveryStefan Knapp
EMBO Molecular Medicine|August 7, 2013
Testis specific gene expression drives disease progression and Rituximab resistance in lymphomaStefan Knapp
Structure (London, England : 1993)|August 15, 2009
Out of the box binding determines specificity of SH2 domain interactionSusanne Müller, Stefan Knapp
Biochimica Et Biophysica Acta|October 27, 2009
Insights into protein kinase regulation and inhibition by large scale structural comparisonJeyanthy Eswaran, Stefan Knapp
Nature Chemical Biology|October 16, 2023
Improving data quality in chemical biologyStefan Knapp, Susanne Müller
Current Opinion in Pharmacology|August 13, 2014
Recently targeted kinases and their inhibitors-the path to clinical trialsStefan Knapp, Michael Sundström
Expert Opinion on Drug Discovery|July 25, 2012
Targeting kinases for the treatment of inflammatory diseasesSusanne Müller, Stefan Knapp
Trends in Biotechnology|July 19, 2018
Chemoproteomics and Chemical Probes for Target DiscoveryGerard Drewes, Stefan Knapp
Nature Reviews. Drug Discovery|April 23, 2014
Targeting bromodomains: epigenetic readers of lysine acetylationPanagis Filippakopoulos, Stefan Knapp
Pageof 54